Latest news for  (OTC:ISGAF) Stock

Needham analyst Ryan Koontz reiterates Bandwidth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAND#NASDAQ">BAND</a>) with a Hold.

News

Reiteration

Analyst Ratings

BAND

Needham Reiterates Hold on Bandwidth

This represents growth of 5%&nbsp;to&nbsp;8%&nbsp;versus prior-year quarter or&nbsp;6%&nbsp;to&nbsp;9%&nbsp;when excluding&nbsp;1%&nbsp;of estimated currency headwind.

Guidance

Linde Expects Q3 Adjusted EPS Of $3.82 - $3.92, Est $3.95

Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>) with a Buy and maintains $60 price target.

Price Target

IONS

Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target

Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) reported quarterly earnings of $2.55 per share which missed the analyst consensus estimate of $2.93 by 12.97 percent. This is a 17.21 percent decrease over earnings of $3.08 per share from the same period last year. The company reported quarterly sales of $51.181 billion which beat the analyst consensus estimate of $50.795 billion by 0.76 percent. This is a 4.67 percent increase over sales of $48.896 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Chevron Q2 2024 Adj. EPS $2.55 Misses $2.93 Estimate, Sales $51.181B Beat $50.795B Estimate

B of A Securities analyst Bryan Spillane upgrades Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) from Neutral to Buy and raises the price target from $62 to $70.

Upgrades

B of A Securities Upgrades Kellanova to Buy, Raises Price Target to $70

Needham analyst Bernie McTernan maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $40 to $50.

RBLX

Needham Maintains Buy on Roblox, Raises Price Target to $50

NW Natural Holdings Reaffirms Long-Term EPS Growth Rate Target Of 4% To 6% Compounded Annually From 2022 Through 2027

NW Natural Holdings Reaffirms 2024 EPS Guidance Of $2.20 - $2.40, Est $2.29

Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) reported quarterly earnings of $0.24 per share. This is a 250 percent increase over losses of $(0.16) per share from the same period last year. The company reported $76.50 million in sales this quarter. This is a 7.25 percent decrease over sales of $82.48 million the same period last year.

BEDU

Bright Scholar Education Q3 Adj $0.24 Up From $(0.16) YoY, Sales $76.50M Down From $82.48M YoY

Linde (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>) reported quarterly earnings of $3.85 per share which beat the analyst consensus estimate of $3.78 by 1.85 percent. This is a 7.84 percent increase over earnings of $3.57 per share from the same period last year. The company reported quarterly sales of $8.267 billion which missed the analyst consensus estimate of $8.316 billion by 0.59 percent. This is a 0.77 percent increase over sales of $8.204 billion the same period last year.

Linde Q2 2024 Adj. EPS $3.85 Beats $3.78 Estimate, Sales $8.267B Miss $8.316B Estimate

The CEO of EBC Financial Group, David Barrett, offered his perspective on how the U.S. market could react to either Kamala Harris or Donald Trump being elected president.
What Happened: Talking to<a href="https://pro.benzinga.com"> Benzinga</a>, Barrett suggested that the market&#8217;s response to a Trump presidency might be more predictable. Trump&#8217;s policies have historically been beneficial for the oil and gas sectors, banks, financials, and, recently, the crypto markets. However, ESG investments, renewables, and Retail stocks could face challenges under Trump&#8217;s administration.
Conversely, predicting the market&#8217;s reaction to a Harris presidency is more complex. 
&#8220;Harris seems to be a lot harder to predict. It would seem a little simplistic to just imply the Biden policies carry on. She seems to be resetting her stance on several key issues that she ran on in 2020 as she shapes up her campaign against Trump,&#8221; he said.
See Also: <a href="https://www.benzinga.com/news/24/07/40057554/lindsey-graham-says-jd-vance-will-support-trump-unequivocally-they-will-work-together-to-right-the-s?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Lindsey Graham Says JD Vance Will Support Trump &#8216;Unequivocally&#8217; — They Will &#8216;Work Together To Right The Ship At Home And Abroad&#8217;</a>
Barrett also suggested that the recent tech stock dip and bond market rally might be a defensive strategy by investors to reduce exposure volatility and lock in favorable interest rates. He also recommended focusing on companies with strong balance sheets, excellent cash flow, and steady income streams.
Why It Matters: The election race is heating up, with many<a href="https://www.benzinga.com/markets/24/08/40111996/trumps-66-comeback-wall-street-braces-for-tariffs-tax-cuts-and-taiwan-turmoil"> political pundits predicting</a> a win for Trump, especially as his popularity surged after an assassination attempt. His choice of J.D. Vance as his running mate strengthened Trump's position, even winning over more millennial voters.
However, a phenomenon <a href="https://www.benzinga.com/markets/equities/24/08/40095631/researchers-identify-trump-dump-effect-ex-president-is-already-causing-deep-stock-losses-in-comp">dubbed the "Trump Dump"</a> effect is causing a significant downturn in the stock market. This effect was linked to the former president's public criticisms of specific companies and sectors.
Meanwhile, Harris was gaining steam in key areas with a new<a href="https://www.benzinga.com/general/politics/24/07/40086590/harris-vs-trump-vice-president-has-passed-former-president-in-swing-states-could-biden-stepping-"> election poll showing </a>her leading in swing states.
President Joe Biden officially confirmed his decision to withdraw on July 21. Since then, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500, has been on a rollercoaster ride. The ETF is down 1% from July 19 to date.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments.&nbsp;<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Image Via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Analyst Color

Markets

General

Trump's Policies May Boost Oil And Crypto, While Harris Presidency Remains A Market Wild Card, Says Expert: 'A Lot Harder To Predict'

Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) reported quarterly earnings of $0.99 per share which met the analyst consensus estimate. This is a 10 percent increase over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $726.11 million which missed the analyst consensus estimate of $821.32 million by 11.59 percent. This is a 16.78 percent increase over sales of $621.75 million the same period last year.

ARES

Ares Management Q2 Adj EPS $0.99, Inline, Sales $726.11M Miss $821.32M Estimate

Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) with a Buy and lowers the price target from $138 to $119.

IRTC

Needham Maintains Buy on iRhythm Technologies, Lowers Price Target to $119

Third Quarter&nbsp;2024&nbsp;Outlook
For the&nbsp;third quarter&nbsp;of 2024, the Company expects to generate revenue between&nbsp;$117 million&nbsp;and&nbsp;$125 million.
The Company expects&nbsp;third quarter&nbsp;2024 diluted net income per share between&nbsp;$0.10&nbsp;and&nbsp;$0.18, and non-GAAP diluted net income per share between&nbsp;$0.29&nbsp;and&nbsp;$0.37. See &quot;Non-GAAP Financial Measures&quot; below.

PRLB

Protolabs Expects Q3 Revenue Of $117M-$125M Vs. $129.624M Consensus; Sees Adj. EPS Of $0.29-$0.37 Vs. $0.41 Consensus

Stifel analyst Martin Landry upgrades Gildan Activewear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) from Hold to Buy and raises the price target from $39 to $51.

Stifel Upgrades Gildan Activewear to Buy, Raises Price Target to $51

The real estate was acquired by a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign&#39;s captive real estate company, and the acquisition is effective as of August 1, 2024.

ENSG

Ensign Group Acquires Real Estate And Operations Of Greater Southside Health And Rehabilitation, An 76-bed Skilled Nursing Facility, Iowa

Needham analyst Alex Henderson reiterates Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) with a Buy and maintains $135 price target.

Needham Reiterates Buy on Cloudflare, Maintains $135 Price Target

FTAI Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.34) by 52.94 percent. This is a 36.84 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $84.89 million which missed the analyst consensus estimate of $96.80 million by 12.31 percent. This is a 3.73 percent increase over sales of $81.83 million the same period last year.

FTAI Infrastructure Q2 EPS $(0.52) Misses $(0.36) Estimate, Sales $84.89M Miss $96.80M Estimate

BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.17 by 41.18 percent. This is a 33.33 percent decrease over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $2.730 billion which beat the analyst consensus estimate of $2.613 billion by 4.46 percent. This is a 25.98 percent increase over sales of $2.167 billion the same period last year.

BTSG

BrightSpring Health Q2 2024 Adj. EPS $0.10 Misses $0.17 Estimate, Sales $2.730B Beat $2.613B Estimate

Northwest Natural Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWN#NYSE">NWN</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 333.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $211.71 million which missed the analyst consensus estimate of $231.99 million by 8.74 percent. This is a 10.99 percent decrease over sales of $237.86 million the same period last year.

Northwest Natural Hldg Q2 EPS $(0.07) Beats $(0.12) Estimate, Sales $211.71M Miss $231.99M Estimate

BlackRock iShares Core Global Agg Bond UCITS ETF USD Hedg (Acc)

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

News

Latest news for (OTC:ISGAF) Stock